Skip to main content
Top
Published in: Obesity Surgery 7/2016

01-07-2016 | Original Contributions

Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery

Authors: Anne Sophie Schneck, Rodolphe Anty, Albert Tran, Audrey Hastier, Imed Ben Amor, Jean Gugenheim, Antonio Iannelli, Thierry Piche

Published in: Obesity Surgery | Issue 7/2016

Login to get access

Abstract

Background

Only a few recent reports have suggested a correlation between obesity and irritable bowel syndrome (IBS). We aimed to determine the prevalence and severity of IBS in a prospective cohort of obese patients undergoing bariatric surgery in Nice Hospital (France).

Methods

One hundred obese patients were included prospectively before bariatric surgery. A diagnosis of IBS and each subtype was performed according to Rome-III criteria using a Bristol scale for stool consistency. Patients provided information on IBS-related comorbidities, including chronic fatigue, migraine, lower back pain, gastroesophageal reflux disease (GERD), genitourinary problems, and dyspepsia. Patients completed questionnaires to assess the severity of IBS, GERD, psychological factors (anxiety, depression), fatigue, and quality of life.

Results

Thirty patients fulfilled the Rome-III criteria for IBS. There was no difference in age, gender, or BMI between obese patients with or without IBS. Obese patients with IBS reported a significantly higher prevalence of GERD, migraines, lower back pain, genitourinary problems, chronic fatigue, and dyspepsia. Obese patients with IBS had significant higher scores of fatigue, anxiety, depression, and poorer quality of life. Obese patients that had both IBS and GERD had significantly higher IBS severity scores than those without GERD. In a logistic regression model including BMI, anxiety, depression, gender, and GERD score, only anxiety was significantly and independently associated with IBS.

Conclusions

Thirty percent of obese patients had IBS: its severity was not correlated with BMI. However, anxiety was independently associated with IBS, suggesting that psychological factors are key features of IBS, whatever the presence of obesity.
Literature
1.
go back to reference Hruby A, Hu FB. The Epidemiology of obesity: a big picture. Pharmacoeconomics. 2014. Hruby A, Hu FB. The Epidemiology of obesity: a big picture. Pharmacoeconomics. 2014.
2.
go back to reference David K, Kowdley KV, Unalp A, et al. Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49(6):1904–12.CrossRefPubMedPubMedCentral David K, Kowdley KV, Unalp A, et al. Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49(6):1904–12.CrossRefPubMedPubMedCentral
3.
go back to reference Delgado-Aros S, Locke GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed Delgado-Aros S, Locke GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed
4.
go back to reference Talley NJ, Quan C, Jones MP, et al. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.CrossRefPubMed Talley NJ, Quan C, Jones MP, et al. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.CrossRefPubMed
5.
go back to reference Sadik R, Björnsson E, Simrén M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22(1):102–8.CrossRefPubMed Sadik R, Björnsson E, Simrén M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22(1):102–8.CrossRefPubMed
6.
go back to reference Cremonini F, Camilleri M, Clark MM, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes. 2009;33(3):342–53.CrossRef Cremonini F, Camilleri M, Clark MM, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes. 2009;33(3):342–53.CrossRef
7.
go back to reference Clements RH, Gonzalez QH, Foster A, et al. Mc- Dowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.CrossRefPubMed Clements RH, Gonzalez QH, Foster A, et al. Mc- Dowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.CrossRefPubMed
8.
go back to reference Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci. 2010;55(9):2606–13.CrossRefPubMed Roberson EN, Gould JC, Wald A. Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci. 2010;55(9):2606–13.CrossRefPubMed
9.
go back to reference Fysekidis M, Bouchoucha M, Bihan H, et al. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.CrossRefPubMed Fysekidis M, Bouchoucha M, Bihan H, et al. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.CrossRefPubMed
10.
go back to reference Carter D, Beer-Gabel M, Tzur D, et al. Predictive factors for the diagnosis of irritable bowel syndrome in a large cohort of 440,822 young adults. Clin Gastroenterol. 2015;49(4):300–5.CrossRef Carter D, Beer-Gabel M, Tzur D, et al. Predictive factors for the diagnosis of irritable bowel syndrome in a large cohort of 440,822 young adults. Clin Gastroenterol. 2015;49(4):300–5.CrossRef
11.
go back to reference Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19(5):577–82.CrossRefPubMed Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19(5):577–82.CrossRefPubMed
12.
go back to reference Anty R, Dahman M, Iannelli A, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18(6):709–14.CrossRefPubMed Anty R, Dahman M, Iannelli A, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18(6):709–14.CrossRefPubMed
13.
go back to reference NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.
14.
go back to reference Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.CrossRefPubMed Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.CrossRefPubMed
15.
go back to reference Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.CrossRefPubMed Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.CrossRefPubMed
16.
go back to reference Piche T, Ducrotté P, Sabate JM, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6):626–e174.CrossRefPubMed Piche T, Ducrotté P, Sabate JM, et al. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(6):626–e174.CrossRefPubMed
17.
go back to reference Fisk JD, Pontrefact A, Ritvo PF, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Can J Neurol Sci. 1994;18 Suppl 1:S79–83. Fisk JD, Pontrefact A, Ritvo PF, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Can J Neurol Sci. 1994;18 Suppl 1:S79–83.
18.
go back to reference Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95(3):760–7.CrossRefPubMed Huet PM, Deslauriers J, Tran A, et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000;95(3):760–7.CrossRefPubMed
19.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
20.
go back to reference Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57(4):468–73.CrossRefPubMed Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57(4):468–73.CrossRefPubMed
21.
go back to reference Sacher-Huvelin S, Gournay J, Amouretti M, et al. Bruley Des Varannes S, Galmiche JP. Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux. Gastroenterol Clin Biol. 2000;24(10):911–6.PubMed Sacher-Huvelin S, Gournay J, Amouretti M, et al. Bruley Des Varannes S, Galmiche JP. Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux. Gastroenterol Clin Biol. 2000;24(10):911–6.PubMed
22.
go back to reference Dapoigny M, Bellanger J, Bonaz B. Bruley des Varannes S, Bueno L, Coffin B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004;16(10):995–1001.CrossRefPubMed Dapoigny M, Bellanger J, Bonaz B. Bruley des Varannes S, Bueno L, Coffin B, et al. Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol. 2004;16(10):995–1001.CrossRefPubMed
23.
go back to reference Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125(6):1651–9.CrossRefPubMed Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125(6):1651–9.CrossRefPubMed
24.
go back to reference Marshall JK, Thabane M, Garg AX, et al. Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605–11.CrossRefPubMed Marshall JK, Thabane M, Garg AX, et al. Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605–11.CrossRefPubMed
25.
go back to reference Scarpellini E, Lupo M, Iegri C, et al. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. Rev Recent Clin Trials. 2014;9(3):141–7.PubMed Scarpellini E, Lupo M, Iegri C, et al. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. Rev Recent Clin Trials. 2014;9(3):141–7.PubMed
26.
27.
go back to reference Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–61.CrossRefPubMed Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–61.CrossRefPubMed
Metadata
Title
Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery
Authors
Anne Sophie Schneck
Rodolphe Anty
Albert Tran
Audrey Hastier
Imed Ben Amor
Jean Gugenheim
Antonio Iannelli
Thierry Piche
Publication date
01-07-2016
Publisher
Springer US
Published in
Obesity Surgery / Issue 7/2016
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1907-0

Other articles of this Issue 7/2016

Obesity Surgery 7/2016 Go to the issue